Patient Guide: Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 135 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04123366
Status: ACTIVE_NOT_RECRUITING
Condition: Solid Tumors
Phase: PHASE2

Where You Can Participate

This study is available at 135 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Gilbert, Arizona
  • • Sacramento, California
  • • And 132 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007) - Join Clinical Trial NCTNCT04123366

How to Join This Clinical Trial - NCTNCT04123366

Learn how to participate in this PHASE2 trial studying an investigational therapy for Solid Tumors. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Solid Tumors. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Solid Tumors
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04123366 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 135 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35233 - United States

Status: Contact for availability

Clinical Research Site

Gilbert, Arizona 85234 - United States

Status: Contact for availability

Clinical Research Site

Sacramento, California 95817 - United States

Status: Contact for availability

Clinical Research Site

San Francisco, California 94115 - United States

Status: Contact for availability

Clinical Research Site

San Francisco, California 94158 - United States

Status: Contact for availability

Clinical Research Site

Greeley, Colorado 80631 - United States

Status: Contact for availability

Clinical Research Site

Gainesville, Florida 32608 - United States

Status: Contact for availability

Clinical Research Site

Atlanta, Georgia 30322 - United States

Status: Contact for availability

Clinical Research Site

Gainesville, Georgia 30501 - United States

Status: Contact for availability

Clinical Research Site

Marietta, Georgia 30060 - United States

Status: Contact for availability

And 125 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Solid Tumors:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships